Wanbangde Pharmaceutical Holding Group Co.,Ltd.’s Net Profit Dropped 10.5% in First Three Quarters of 2022

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (002082.SZ) reported a net profit of 139.5 million yuan in the first three quarters of 2022, down 10.5% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 8.7% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 31%.